4.6 Article

Tissue Response to Subcutaneously Implanted Recombinant Spider Silk: An in Vivo Study

Journal

MATERIALS
Volume 2, Issue 4, Pages 1908-1922

Publisher

MDPI AG
DOI: 10.3390/ma2041908

Keywords

spider silk; recombinant; biocompatibility; in vivo

Funding

  1. European Commission [G5RD-CT-2002-00738]
  2. Swedish Research Council
  3. Swedish Agency for Innovation Systems
  4. Formas

Ask authors/readers for more resources

Spider silk is an interesting biomaterial for medical applications. Recently, a method for production of recombinant spider silk protein (4RepCT) that forms macroscopic fibres in physiological solution was developed. Herein, 4RepCT and Mersilk(TM) (control) fibres were implanted subcutaneously in rats for seven days, without any negative systemic or local reactions. The tissue response, characterised by infiltration of macrophages and multinucleated cells, was similar with both fibres, while only the 4RepCT-fibres supported ingrowth of fibroblasts and newly formed capillaries. This in vivo study indicates that 4RepCT-fibres are well tolerated and could be used for medical applications, e. g., tissue engineering.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available